Clinical Trials Browser

Phase 3 × Vomiting × Drug Therapy × Clear all

NCT02116530 2025-01-28

Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy

Phase 3 Completed

401 enrolled 14 charts

Other hematologic neoplasm

Nausea, Vomiting, Hematologic Neoplasms